$E-mini NASDAQ 100 Futures(MAR5) (NQmain.US)$
MM will want to kill the 525 puts. otherwise reverse gamma.

$VIX Index Futures(FEB5) (VXmain.US)$ vix touch 18.8. if it pass is a huge reverse gamma squeeze

We are in a bifurcated market where there are opportunities in either long or short direction since Nov.
Many growth stocks like $Sea (SE.US)$, $Twilio (TWLO.US)$, $Unity Software (U.US)$, $CrowdStrike (CRWD.US)$ $Affirm Holdings (AFRM.US)$ $Fiverr International (FVRR.US)$ $Roku Inc (ROKU.US)$ $MercadoLibre (MELI.US)$ $DocuSign (DOCU.US)$ $PayPal (PYPL.US)$ are deeply oversold (30-60%).
Or as per Cathie Wood, they are in deep value zone.
Some of them showed relative strength against the $S&P 500 Index (.SPX.US)$ and near the support. There are some entry setups with decent reward to risk.
Possible to ride the overdued short term up swing after oversold with the current or aka the coming Santa Claus rally.

Moderna Booster Protect from Omicron!
like the comment for the green day ahead✌🏻
https://www.cnbc.com/amp/2021/12/20/moderna-says-booster-of-its-covid-vaccine-appears-to-protect-against-omicron.html
$Portillo’s Inc. (PTLO.US)$  $Tesla (TSLA.US)$  $Lucid Group (LCID.US)$  $Gores Guggenheim (GGPI.US)$  $Grab Holdings (GRAB.US)$  $Apple (AAPL.US)$  $Meta Platforms (FB.US)$  $Microsoft (MSFT.US)$  $Nasdaq Composite Index (.IXIC.US)$  $Advanced Micro Devices (AMD.US)$  $Moderna (MRNA.US)$

I started my investment journey in Aug 2021. Been there in both Moomoo and Tiger promotions. Moomoo's app GUI and typesetting won me over with the ease of use. The multitude of functions such as Options Trading, Level 2 quotes and Stock Analysis aided me tremendously in my trading journey. Allow me to recap my five months of learning journey:
****************************************
Chapter 1: Noob Start in Local and My 1st Option Trade  - Aug 2021
My initial strategy is to invest into local market: (1) Invest in Bank and REITS.
"Could be better" Trade: FOMO into dividend bank stock $OCBC Bank (O39.SG)$ and been bag-holding till now. Did not know that after ex-dividend, the stock will usually tank equivalent to dividend amount.
In the same month, I learnt about Options Trading. I made my 1st CSP on $Coinbase (COIN.US)$, and closing early to make a tidy profit. I also learnt that I do not need to maintain full securities to cover CSP as Moomoo allows Margin account to cover the principal.
Transaction
Note: Moomoo is great to support both Cash Secured Puts (CSP) and Covered Calls (CC) which will allow the possible implementation of Wheel Strategy.
******************************************
Chapter 2: Options and it's danger - Sep to Oct 2021
Revised Strategy: (1) Invest in Bank & REITS (2) Income through Selling Puts
I intensified on Options trading specifically on selling puts to generate income. Although CSP provides premium as income stream, there is a risk of unlimited downside if the underlying stock price goes down quickly. This happened to me when $Adobe (ADBE.US)$ tanked from 600+ to 500+.
Learning Point: Be cognisant of unlimited downside risk for selling puts. Learn how to roll down and out if needed. Disclaimer: DYODD
***************************************
Chapter 3: Discovering joy of Scalp Trading - Nov 2021
Enhanced Strategy: (1) Invest in Bank & REITS; (2) Income through Selling Puts; (3) Scalp Trading
I started day trading in Nov. I learnt about basics of technical analysis and uses candlesticks, EMA and VWAP for Scalp trade. In Nov, I made a total of 131 trades with ~1.65 mil in turnover . However, I only made 0.18% in profits which is good enough for me.
Transaction Stats
Good Trade: $BioNTech (BNTX.US)$ Took the scalp trade on 3 green 🕯. Exited quickly after 3 mins trade
Learning Points: Separate investment and trading, Curb emotions, do not FOMO, set Stop Limits for both profits and losses, Accept losses gracefully.
***************************************
Chapter 4: Leaps into the future - Dec 2021
Tweaked Strategy: (1) Invest in Bank & REITS; (2) Income through Selling Puts; (3) Scalp Trading and (4) Control future with LEAPS
The last month of 2021 saw extreme volatilities in equity market. My long-term portfolio shrank by 15%. I added another option strategy: LEAPS into my investment plan. LEAPS entails buying long option calls deep into future (1 year or more). I added two stocks that I feel that will rise by Jan 2023: $Palantir (PLTR.US)$ $SoFi Technologies (SOFI.US)$
Tips: Buy ITM LEAPS when the underlying stock price is low or reached certain pressure lines. Disclaimer: DYODD
***************************************
In Summary
It has been a rewarding and fruitful learning journey in investing. Although I missed out the initial QE ride last year, the painful lessons I learnt now in 2021 will be useful for my future trades. I will continue to fine-tune my investment strategy to improve my expertise in 2022.
Many thanks to Moomoo for the great contents such as News, Courses, Seminars etc and not forgetting the selfless sharing of experiences by fellow Moo-ers!!
"Looking forward from Moomoo":
(1) Advanced options strategy such as Iron Condor and Credit Spreads
(2) Crypto Trading

$PayPal (PYPL.US)$ $Affirm Holdings (AFRM.US)$
As titled. I know some of the big BNPL players are getting probed and it's been commented that they need to be regulated for reasons such as putting more people in debt, lack of credit check etc. It's scary that some online sites set user's default payment method as BNPL, but I do understand that this kind of payment plan can have some user benefits.
Wondering if people think BNPL stocks are worth investing? Thanks.

$Sanofi (SNY.US)$ $GlaxoSmithKline (GSK.US)$ $Pfizer (PFE.US)$ $BioNTech (BNTX.US)$ $Moderna (MRNA.US)$ French drugmaker Sanofi and its British partner GlaxoSmithKline said on Wednesday a single booster dose of their recombinant adjuvanted COVID-19 vaccine candidate delivered consistently strong immune responses.
"The booster was well tolerated, with a safety profile similar to currently approved COVID-19 vaccines. This is the most comprehensive booster trial to date to explore boosting across different vaccine technologies used for primary vaccination", the two companies said in a statement.
At the end of September, Sanofi dropped its plans for its own mRNA-based COVID-19 vaccine because of the dominance achieved by BioNTech-Pfizer and Moderna in using the technology to fight the pandemic.
Sanofi is hoping for a comeback after falling behind rivals in the race for COVID-19 shots with a vaccine candidate based on the more conventional protein-based approach.
"The ongoing global Phase 3 trial ... includes regular reviews by an independent Data Safety Monitoring Board (DSMB). During its last review, the DSMB identified no safety concerns and recommended the trial to continue into early 2022 to accrue more data," the companies said.

$Invesco QQQ Trust (QQQ.US)$ $Pfizer (PFE.US)$ $Moderna (MRNA.US)$ British Prime Minister Johnson said on Monday that at least one person in the UK has died after contracting the Omicron variant of the new crown virus. This is the first death in the world where this virus variant has been publicly confirmed. The United Kingdom did not provide details on the death case, only that the person was diagnosed in the hospital. It is unclear whether the patient has been vaccinated or has underlying health problems. Omicron deaths may have occurred in other countries, but they have not been publicly confirmed outside the UK.
Article excerpted from Reuters Financial Morning Post